首页> 外文期刊>Journal of Virological Methods >Transcriptional activity comparison of different sites in recombinant Marek's disease virus for the expression of the H9N2 avian influenza virus hemagglutinin gene
【24h】

Transcriptional activity comparison of different sites in recombinant Marek's disease virus for the expression of the H9N2 avian influenza virus hemagglutinin gene

机译:重组马立克氏病病毒不同位点对H9N2禽流感病毒血凝素基因表达的转录活性比较

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Over the last two decades, much attention has been paid to MDV-vectored recombinant vaccines. Many factors have influenced their protective efficacy, and insertion site has been among the main influential factors for the expression of foreign genes in recombinant Marek's disease virus (rMDV). To compare the transcriptional activity of different sites of rMDV, an H9N2 avian influenza virus hemagglutinin gene (AIV-H9N2-HA) expression cassette that used the bi-directional promoter of serotype 1 MDV (MDV1) in the 1.8 kb RNA transcript direction (p1.8 kb) as a promoter was inserted into 4 different regions of MDV using the bacterial artificial chromosome (BAC) vector and FLP/FRT recombination technique. The insertion regions included 3 of its own sites (US2, US10 and one of Meq genes) in the MDV genome and a foreign site (gpt gene) in the BAC vector. Quantitative PCR and enzyme-linked immunosorbent assay (ELISA) were used to analyze and compare the H9N2-HA expression levels of these different rMDVs both at the mRNA level and at the protein level. The results indicated that among the four tested insertion regions, the HA expression cassette in the US2 region demonstrated the highest activity, followed by that in the Meq region, which was almost equal to that of US10. Further, the expression cassette had the lowest activity in the foreign region gpt gene. The above data could be useful for choosing proper recombinant insertion regions in the construction of rMDV to express different foreign genes, and it is a prerequisite for developing effective MDV-vectored recombinant vaccines. (C) 2014 Elsevier B.V. All rights reserved.
机译:在过去的二十年中,已经非常重视MDV载体重组疫苗。许多因素影响了它们的保护功效,并且插入位点已成为重组马立克氏病病毒(rMDV)中外源基因表达的主要影响因素。为了比较rMDV不同位点的转录活性,使用了H1N2禽流感病毒血凝素基因(AIV-H9N2-HA)表达盒,该表达盒在1.8 kb RNA转录方向上使用了血清型1 MDV(MDV1)的双向启动子(p1使用细菌人工染色体(BAC)载体和FLP / FRT重组技术,将.8 kb)作为启动子插入MDV的4个不同区域。插入区在MDV基因组中包含3个自身位点(US2,US10和Meq基因之一),在BAC载体中包含一个外来位点(gpt基因)。定量PCR和酶联免疫吸附测定(ELISA)用于分析和比较这些不同rMDV在mRNA水平和蛋白水平的H9N2-HA表达水平。结果表明,在四个测试的插入区中,US2区的HA表达盒显示出最高的活性,其次是Meq区,与US10几乎相等。此外,表达盒在异域gpt基因中具有最低的活性。以上数据对于在rMDV的构建中选择合适的重组插入区以表达不同的外源基因可能是有用的,并且这是开发有效的MDV载体重组疫苗的先决条件。 (C)2014 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号